Rollover Study to Provide Continued Access to TT-00420 (Tinengotinib) for Subjects With Advanced Solid Tumors

Conditions: Advanced Solid Tumors; Cholangiocarcinoma Interventions: Drug: Tinengotinib Sponsors: TransThera Sciences (Nanjing), Inc. Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials